-
In this paper, fang and colleagues compared five different risk stratification schemes as predictors of thromboembolism in patients with nonvalvular atrial fibrillation.
-
Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
-
Certain asymptomatic patients with significant aortic regurgitation (AR) and preserved left ventricular (LV) function may be at high risk for mortality.
-
-
-
The greatest challenge for any potentially mortal disorder is to prove that therapeutic interventions reduce not only disease-specific mortality, but also all-cause mortality.
-
This single center prospective observational study finds that the utility of a routine daily chest x-ray (CXR) for an ICU patient is quite limited. A change in practice to ordering CXR only when clinically indicated did not adversely impact patient outcome but reduced CXR volume and overall costs.
-
Neither training in working techniques nor use of lifting equipment appears to prevent back pain or back-related disability.
-
Lower serum testosterone in men aged 60 and over was associated with increased fracture risk (especially hip and nonvertebral), even after adjusting for other major risk factors for fracture.
-
Wyeth Pharmaceuticals has received approval to market desvenlafaxine for the treatment of depression. The drug is the major active metabolite of venlafaxine (Effexor ). Wyeth has formulated the drug in a once-daily extended-release tablet. It will be marketed under the trade name Pristiq.